Search

Your search keyword '"Kung, Andrew L."' showing total 672 results

Search Constraints

Start Over You searched for: Author "Kung, Andrew L." Remove constraint Author: "Kung, Andrew L." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
672 results on '"Kung, Andrew L."'

Search Results

1. Clonal evolution during metastatic spread in high-risk neuroblastoma

2. Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients

3. Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm

5. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

6. Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation

7. Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors

8. Therapeutic targeting of ATR in alveolar rhabdomyosarcoma

9. Antithymocyte globulin exposure in CD34+ T-cell–depleted allogeneic hematopoietic cell transplantation

10. Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation

11. Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy

12. Regulatory T Cell Reconstitution Is Associated with Acute Graft-Versus-Host Disease in Pediatric and Young Adult Hematopoietic Cell Transplant Recipients

13. Predictors for Recent Thymic Emigrant T Cell Reconstitution after Hematopoietic Cell Transplantation

14. Abstract PR01: Identification and pharmacological targeting of treatment-resistant, stem-like breast cancer cells for combination therapy

17. High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines

18. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

20. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL

21. BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway

22. Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy

23. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma

24. Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma

25. Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations

27. BET bromodomain proteins regulate enhancer function during adipogenesis

29. Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy

31. Clonal hematopoiesis in survivors of childhood cancer

32. Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

33. Data from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

34. Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach

35. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors

36. A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

39. Abstract 2149: A whole genome sequencing classifier of homologous recombination deficiency

40. Abstract 3142: Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology

41. Supplementary Table S1.4 from Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer

42. Data from Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma

43. Supp. Table 2 from Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma

44. Supplementary Table 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

45. Data Supplement from Antiproliferative Effects of CDK4/6 Inhibition in CDK4-Amplified Human Liposarcoma In Vitro and In Vivo

46. Data from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

47. Supplementary Table 1 from Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion–Driven Cancer

48. Supplementary Figure 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

50. Supplementary Data from Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion–Driven Cancer

Catalog

Books, media, physical & digital resources